Clinical Trial Update: Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating interim 18F-FLT PET/CT to predict outcomes in pancreatic adenocarcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2022-11-08